Health & Fitness
Health and Fitness
Health and Fitness
Wed, November 9, 2011
Tue, November 8, 2011
Misonix Schedules First Quarter Fiscal 2012 Financial Results Conference Call;; November 9, 2011 at 4:30 p.m. Eastern
Misonix Schedules First Quarter Fiscal 2012 Financial Results Conference Call; November 9,... -- FARMINGDALE, N.Y., Nov. 8, 2011 /PRNewswire/ --
Misonix Schedules First Quarter Fiscal 2012 Financial Results Conference Call; November 9, 2011 at 4:30 p.m. Eastern
FARMINGDALE, N.Y., Nov. 8, 2011 /PRNewswire/ -- Misonix, Inc. (NASDAQ: [ MSON ]), a medical device company that designs, manufactures, and markets innovative therapeutic ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, today announced plans to release first quarter ended September 30, 2011 financial results on Wednesday, November 9, 2011. Michael A. McManus, President and Chief Executive Officer and Richard Zaremba, Senior VP and Chief Financial Officer, will host a conference call at 4:30 p.m. Eastern on Wednesday, November 9, 2011 to discuss the Company's first quarter 2012 financial results.
Shareholders and other interested parties may participate in the conference call by dialing 866 783 2138 (domestic) or 857 350 1597 (international) and entering access code 31240745, a few minutes before the start of the call. A simultaneous webcast will be available via Misonix's website at [ www.misonix.com ]. The call will be archived on the Company's website for at least 90 days.
A recording of the live-call will be available approximately 2 hours after the event through November 16, 2011. The dial-in number to listen to the recording is 888 286 8010 or 617 801 6888. The replay access code is 74394535.
About Misonix:
Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at [ www.misonix.com ].
Investor Relations Contact:
Kevin M. McGrath
Cameron Associates, Inc.
212 245 4577
[ Kevin@cameronassoc.com ]
SOURCE Misonix, Inc.
[ Back to top ] RELATED LINKS
[ http://www.misonix.com ]
